Intersect ENT Commences Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Intersect ENT (XENT) Prices Larger 3.58M Common Offering at $25/Share
June 3, 2015 11:29 AM EDTIntersect ENT (NASDAQ: XENT) is up over 3 percent Wednesday after the company announced the upsizing and pricing of its underwritten public offering. The size of the offering has been increased from the previously announced 3,000,000 shares of common stock to 3,582,000 shares of common... More
Intersect ENT (XENT) Commences 3M Common Stock Offering
June 1, 2015 4:04 PM EDTIntersect ENT (NASDAQ: XENT) announced the commencement of an underwritten public offering of 3,000,000 shares of its common stock to be sold by the company. In addition, the company expects to grant the underwriters a 30-day option to purchase up to an additional 450,000... More
